DIETARY_SUPPLEMENT · Unmapped registry intervention
green tea extract
Find medicine records ·
Find other trials using this name
Clinical trial
Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery
NCT01912820
Drugs and interventions used in this trial
5 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
quercetin
Normalized identity: quercetinView linked drug · Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
placebo
Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
therapeutic conventional surgery
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
laboratory biomarker analysis
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Recurrent Prostate Cancerunresolved
Stage I Prostate Cancerunresolved
Stage IIA Prostate Cancerunresolved
Stage IIB Prostate Cancerunresolved
Stage III Prostate Cancerunresolved
Stage IV Prostate Cancerunresolved
Interventions
green tea extractDIETARY_SUPPLEMENT
quercetinDRUG · verified · RxNorm: quercetin
placeboOTHER
therapeutic conventional surgeryPROCEDURE
Sponsors & collaborators
Jonsson Comprehensive Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01912820 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.